<DOC>
	<DOC>NCT01023841</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of bimatoprost solution 0.03% once daily application to the upper eyelid margins compared with vehicle in treating eyelash loss or hypotrichosis (inadequate or not enough eyelashes) in children.</brief_summary>
	<brief_title>Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Hypotrichosis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Children who have inadequate eyelashes or have lost their eyelashes as a result of chemotherapy treatment, who completed their chemotherapy (intensive treatment) at least 4 weeks before starting the study, are considered to be at low risk for relapse of their cancer, and are well enough to complete the study Children who have minimal to moderate inadequate eyelashes due to alopecia areata Adolescents between the ages of 1517 years who have minimal to marked inadequate eyelashes Any eye disease or abnormality, eye surgery, permanent eyeliner, eyelash implants. Semipermanent eyelash tint, dye or eyelash extension application within 3 months Use of over the counter eyelash growth products within 6 months. Use of prescription eyelash growth products (eg, LatisseÂ®) Any eye condition that would prevent required ophthalmology exams</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>